FH535 Inhibits Proliferation and Motility of Colon Cancer Cells by Targeting Wnt/β-catenin Signaling Pathway

Aberrant Wnt/β-catenin pathway activation is frequently observed in human colorectal cancer (CRC) and has become a promising target for CRC treatment. Our study aimed to evaluate the effect of FH535, a small molecule inhibitor of Wnt/β-catenin pathway, on two colon cancer cell lines, HT29 and SW480....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yanyan, Rao, Xianping, Huang, Kangmao, Jiang, Xiaoxia, Wang, Haohao, Teng, Lisong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665030/
https://www.ncbi.nlm.nih.gov/pubmed/29158786
http://dx.doi.org/10.7150/jca.19273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665030/
https://www.ncbi.nlm.nih.gov/pubmed/29158786
http://dx.doi.org/10.7150/jca.19273

Ejemplares similares